[Combination chemotherapy with cis-diamminedichloroplatinum (CDDP) and other anticancer agents for patients with advanced esophageal cancer]. 1985

T Yoshihara, and M Niimoto, and T Hirai, and Y Miyoshi, and S Ohtagaki, and T Hattori

Combination chemotherapy with cis-diamminedichloroplatinum (CDDP) and other anticancer agents was performed in patients with advanced esophageal cancer. From July 1982 to September 1984, 16 patients were entered into this study and divided into two regimens. In regimen I, 5 patients were treated with a daily dose of 20 mg CDDP and 10 mg Peplomycin for five consecutive days and 10 mg Mitomycin C on the first day. This course was repeated 2 or 3 times every 4 weeks. As for evaluation, 1 PR (20%) and 4 NC (80%) were observed. In regimen II, nine patients were treated with daily doses of 25 mg CDDP and 2 mg Vindesine for 5 consecutive days, a course which was repeated every 4 weeks. As for evaluation, 1 CR (9%), 1 PR (9%), 4 MR (36%), 2NC (18%), and 3 PD (27%) were observed. Major side effects were renal failure, bone marrow suppression, nausea and vomiting, which were mostly transient. However, more severe bone marrow suppression was observed in regimen I composed with regimen II.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005260 Female Females

Related Publications

T Yoshihara, and M Niimoto, and T Hirai, and Y Miyoshi, and S Ohtagaki, and T Hattori
February 1985, Gan no rinsho. Japan journal of cancer clinics,
T Yoshihara, and M Niimoto, and T Hirai, and Y Miyoshi, and S Ohtagaki, and T Hattori
November 1990, Nihon Gan Chiryo Gakkai shi,
T Yoshihara, and M Niimoto, and T Hirai, and Y Miyoshi, and S Ohtagaki, and T Hattori
February 1985, Hinyokika kiyo. Acta urologica Japonica,
T Yoshihara, and M Niimoto, and T Hirai, and Y Miyoshi, and S Ohtagaki, and T Hattori
April 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
T Yoshihara, and M Niimoto, and T Hirai, and Y Miyoshi, and S Ohtagaki, and T Hattori
April 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
T Yoshihara, and M Niimoto, and T Hirai, and Y Miyoshi, and S Ohtagaki, and T Hattori
August 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
T Yoshihara, and M Niimoto, and T Hirai, and Y Miyoshi, and S Ohtagaki, and T Hattori
December 1981, Cancer,
T Yoshihara, and M Niimoto, and T Hirai, and Y Miyoshi, and S Ohtagaki, and T Hattori
May 1984, Gan no rinsho. Japan journal of cancer clinics,
T Yoshihara, and M Niimoto, and T Hirai, and Y Miyoshi, and S Ohtagaki, and T Hattori
December 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
T Yoshihara, and M Niimoto, and T Hirai, and Y Miyoshi, and S Ohtagaki, and T Hattori
January 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!